DVOŘÁK, Petr, Pavel KREJČÍ, Lukáš BÁLEK, Lívia EISELLEOVÁ, Žaneta KONEČNÁ, Pavel DVOŘÁK, David BEDNÁŘ, Jan BREZOVSKÝ, Eva ŠEBESTOVÁ, Radka CHALOUPKOVÁ, Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ and Michaela BOSÁKOVÁ. Thermostable FGF2 Polypeptide, Use Thereof. 2021.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Thermostable FGF2 Polypeptide, Use Thereof
Authors DVOŘÁK, Petr (203 Czech Republic, guarantor, belonging to the institution), Pavel KREJČÍ (203 Czech Republic, belonging to the institution), Lukáš BÁLEK (203 Czech Republic, belonging to the institution), Lívia EISELLEOVÁ (703 Slovakia, belonging to the institution), Žaneta KONEČNÁ (203 Czech Republic, belonging to the institution), Pavel DVOŘÁK (203 Czech Republic, belonging to the institution), David BEDNÁŘ (203 Czech Republic, belonging to the institution), Jan BREZOVSKÝ (203 Czech Republic, belonging to the institution), Eva ŠEBESTOVÁ (203 Czech Republic, belonging to the institution), Radka CHALOUPKOVÁ (203 Czech Republic, belonging to the institution), Veronika ŠTĚPÁNKOVÁ, Pavel VAŇÁČEK, Zbyněk PROKOP, Jiří DAMBORSKÝ (203 Czech Republic, belonging to the institution) and Michaela BOSÁKOVÁ (203 Czech Republic, belonging to the institution).
Edition Number: SG11201804402W, Publisher: Intellectual Property Office of Singapore (IPOS), Place of publication: Singapur, Owner's name: Masarykova univerzita; Enantis s.r.o. 2021.
Other information
Original language English
Type of outcome Patent
Country of publisher Singapore
Confidentiality degree is not subject to a state or trade secret
WWW URL
RIV identification code RIV/00216224:14310/21:00121632
Organization Přírodovědecká fakulta – Repository – Repository
Keywords in English Fibroblast Growth Factor 2; FGF2
Links LO1214, research and development project.
Changed by Changed by: RNDr. Daniel Jakubík, učo 139797. Changed: 1/6/2022 02:28.
Abstract
The invention provides an isolated thermostable polypeptide possessing FGF2 activity and having at least 85% sequence identity to SEQ ID NO: 2 (FGF2 wt) or a functional fragment thereof, and comprising at least one amino acid substitution R31L and the use thereof in the cell biology research, regenerative medicine and related medical applications or cosmetics. Further it discloses a culture medium comprising subjected FGF2 suitable for culturing a human pluripotent stem cells involving both human embryonic stem cells and induced pluripotent stem cells.
Type Name Uploaded/Created by Uploaded/Created Rights
40469SG2-CERT.PDF   File version 1/6/2022

Properties

Name
40469SG2-CERT.PDF
Address within IS
https://repozitar.cz/auth/repo/50586/1307945/
Address for the users outside IS
https://repozitar.cz/repo/50586/1307945/
Address within Manager
https://repozitar.cz/auth/repo/50586/1307945/?info
Address within Manager for the users outside IS
https://repozitar.cz/repo/50586/1307945/?info
Uploaded/Created
Wed 1/6/2022 02:28

Rights

Right to read
  • anyone on the Internet
Right to upload
 
Right to administer:
  • a concrete person Mgr. Lucie Vařechová, uco 106253
  • a concrete person RNDr. Daniel Jakubík, uco 139797
  • a concrete person Mgr. Jolana Surýnková, uco 220973
Attributes
 
Print
Add to clipboard Displayed: 18/4/2024 13:24